Pharmacovigilance of quality deviations in the public healthcare system
Drug quality deviation (DQD) is the disagreement with the parameters at the registration with after commercialization step. Pharmacovigilance programs should be notified of DQD to ensure drug efficacy and support patient safety. Objective: To describe DQD from public healthcare system and its im...
Saved in:
Main Authors: | Carolina Resende Bitencourt, Cristiane Aparecida Menezes De Pádua, Paula Lana De Miranda Drummond, Edson Perini |
---|---|
Format: | article |
Language: | EN PT |
Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/b5da99e20a1c4a8a97b339708dbc50ab |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence-based Appraisal of the CARAVAGGIO Trial
by: Tiffany Khieu, et al.
Published: (2021) -
Type 2 Diabetes Mellitus in Patients with a Prior History of Corticosteroid-induced Hyperglycemia
by: Jennifer Levine DeZubay, et al.
Published: (2019) -
A proposal for pharmacovigilance data restructuring at the teaching hospital
by: Sayuri R. Yamashita, et al.
Published: (2020) -
Guest editorial: The ten most important qualities for the profession of medicinal research
by: Tony Y. Zhang
Published: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
by: Nicole D. Avant
Published: (2021)